The effect of disturbed flow regulation on endothelial histone demethylase KDM5B and H3K4me3 on carotid plaque formation
Author:
Affiliation:

The Ninth Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215200, China)

Clc Number:

R5;R363

  • Article
  • | |
  • Metrics
  • |
  • Reference [24]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Aim To investigate whether disturbed flow affects endothelial cell function and atherosclerotic plaque formation by regulating histone demethylase KDM5B and epigenetic modification. Methods After partial carotid artery ligation (PCL), single-cell data analysis and immunofluorescence staining were used to investigate the changes of histone methylation level and histone demethylase expression in carotid endothelial cells of wild type mice under perturbed flow. qPCR and Western blot were used to detect the expression of KDM5B and H3K4me3 in endothelial cells exposed to disturbed flow. Transcriptome sequencing was used to analyze the effect of KDM5B knockdown on endothelial cell function.Endothelial cell ring formation assay was used to verify the effect of KDM5B on angiogenesis. PCL combined with high-fat diet for 2 weeks was used to establish a carotid artery plaque model to analyze the effect of KDM5B knockdown on plaque formation. Results There was a large amount of H3K4me3 methylation in vascular endothelial cells. Blood disturbed flow reduced the methylation of H3K4me3 (P<0.01) and promoted the expression of histone demethylases KDM5B in endothelial cells (P<0.05). Compared with control group, inhibition of KDM5B activity or knockdown of KDM5B increased H3K4me3 level in endothelial cells (P<0.05). Compared with Con313 control group, KDM5B knockdown reduced atherosclerotic plaque formation by 41.45% (Con313 control group:42.17%±1.90%, shKDM5B knockdown group:24.69%±1.60%, P<0.01) by inhibiting angiogenesis. Conclusions Blood disturbed flow promotes KDM5B expression, reduces H3K4me3 modification, and promotes angiogenesis and atherosclerotic plaque formation. Targeting the KDM5B-H3K4me3 axis can be used as a candidate therapeutic target related to cardiovascular diseases.

    Reference
    [1] KRUGER-GENGE A, BLOCKI A, FRANKE R P, et al.Vascular endothelial cell biology:an update.Int J Mol Sci, 9,0(18):4411.
    [2] LEHOUX S, CASTIER Y, TEDGUI A.Molecular mechanisms of the vascular responses to haemodynamic forces.J Intern Med, 6,9(4):381-392.
    [3] 吴丽丽, 朱力.Semaphorin家族在动脉粥样硬化中的作用.中国动脉硬化杂志, 1,9(8):645-651.WU L L, ZHU L.The role of semaphorin family in atherosclerosis.Chin J Arterioscler, 1,9(8):645-651.
    [4] TEO A Y Y, SQUAIR J W, COURTINE G, et al.Best practices for differential accessibility analysis in single-cell epigenomics.Nat Commun, 4,5(1):8805.
    [5] 张晓璐, 耿妙颖, 王雲, 等.N6-甲基腺苷修饰在动脉粥样硬化中的作用及药物干预的研究进展.中国动脉硬化杂志, 4,2(4):277-284.ZHANG X L, GENG M Y, WANG Y, et al.Research progress on the role of N6-methyladenosine modification in atherosclerosis and drug intervention.Chin J Arterioscler, 4,2(4):277-284.
    [6] BLACK J C, VAN RECHEM C, WHETSTINE J R.Histone lysine methylation dynamics:establishment, regulation, and biological impact.Mol Cell, 2,8(4):491-507.
    [7] MARTIN C, ZHANG Y.The diverse functions of histone lysine methylation.Nat Rev Mol Cell Biol, 5,6(11):838-849.
    [8] LIU B, KUMAR R, CHAO H P, et al.Evidence for context-dependent functions of KDM5B in prostate development and prostate cancer.Oncotarget, 0,1(46):4243-4252.
    [9] ALBERT M, SCHMITZ S U, KOOISTRA S M, et al.The histone demethylase Jarid1b ensures faithful mouse development by protecting developmental genes from aberrant H3K4me3.PLoS Genet, 3,9(4):e1003461.
    [10] ZHANG S M, CAI W L, LIU X, et al.KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements.Nature, 1,8(7882):682-687.
    [11] HINOHARA K, WU H J, SEBASTIEN V, et al.KDM5 histone demethylase activity links cellular transcriptomic heterogeneity to therapeutic resistance.Cancer Cell, 9,5(2):330-332.
    [12] WANG B, TAN Y, ZHANG Y, et al.Loss of KDM5B ameliorates pathological cardiac fibrosis and dysfunction by epigenetically enhancing ATF3 expression.Exp Mol Med, 2,4(12):2175-2187.
    [13] FORK C, GU L, HITZEL J, et al.Epigenetic regulation of angiogenesis by JARID1B-induced repression of HOXA5.Arterioscler Thromb Vasc Biol, 5,5(7):1645-1652.
    [14] CAO Y C, SHAN S K, GUO B, et al.Histone lysine methylation modification and its role in vascular calcification.Front Endocrinol (Lausanne), 2,3:863708.
    [15] REZVAN A, NI C W, ALBERTS-GRILL N, et al.Animal, in vitro, and ex vivo models of flow-dependent atherosclerosis:role of oxidative stress.Antioxid Redox Signal, 1,5(5):1433-1448.
    [16] TANG C, CHEN G, WU F, et al.Endothelial CCRL2 induced by disturbed flow promotes atherosclerosis via chemerin-dependent β2 integrin activation in monocytes.Cardiovasc Res, 3,9(9):1811-1824.
    [17] LI F, YAN K, WU L, et al.Single-cell RNA-seq reveals cellular heterogeneity of mouse carotid artery under disturbed flow.Cell Death Discov, 1,7(1):180.
    [18] DONG X, HU H, FANG Z, et al.CTRP6 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration.Biomed Pharmacother, 8,3:844-850.
    [19] CHIU J J, CHIEN S.Effects of disturbed flow on vascular endothelium:pathophysiological basis and clinical perspectives.Physiol Rev, 1,1(1):327-387.
    [20] MANEA S A, VLAD M L, LAZAR A G, et al.Pharmacological inhibition of lysine-specific demethylase 1A reduces atherosclerotic lesion formation in apolipoprotein E-deficient mice by a mechanism involving decreased oxidative stress and inflammation; potential implications in human atherosclerosis.Antioxidants (Basel), 2,1(12):2382.
    [21] BLAIR L P, CAO J, ZOU M R, et al.Epigenetic regulation by lysine demethylase 5 (KDM5) enzymes in cancer.Cancers (Basel), 1,3(1):1383-1404.
    [22] WANG S, MIAO J, QU M, et al.Adiponectin modulates the function of endothelial progenitor cells via AMPK/eNOS signaling pathway.Biochem Biophys Res Commun, 7,3(1):64-70.
    [23] 雷雪丽, 王震.中药天然产物调控内皮细胞防治动脉粥样硬化的研究进展.中国动脉硬化杂志, 3,1(1):70-79.LEI X L, WANG Z.Research progress on the regulation of endothelial cells by natural products of traditional Chinese medicine in the prevention and treatment of atherosclerosis .Chin J Arterioscler, 3,1(1):70-79.
    [24] LI C Y, WANG W, LEUNG C H, et al.Kdm5 family as therapeutic targets in breast cancer:pathogenesis and therapeutic opportunities and challenges.Mol Cancer, 4,3(1):109.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

WU Lili, SHEN Yu. The effect of disturbed flow regulation on endothelial histone demethylase KDM5B and H3K4me3 on carotid plaque formation[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2025,33(2):117-124.

Copy
Share
Article Metrics
  • Abstract:36
  • PDF: 391
  • HTML: 0
  • Cited by: 0
History
  • Received:October 26,2024
  • Revised:January 21,2025
  • Online: March 05,2025
Article QR Code